Form 8-K GLOBUS MEDICAL INC For: Aug 06

Go back to Form 8-K GLOBUS MEDICAL INC For: Aug 06

Globus Medical (GMED) PT Raised to $78 at RBC Capital

August 7, 2024 7:00 AM EDT

RBC Capital analyst Shagun Singh raised the price target on Globus Medical (NYSE: GMED) to $78.00 (from $76.00) while maintaining a Outperform rating.

The analyst comments "GMED issued Q2 results, delivering an upside surprise of 2% and 11% in sales and EPS, respectively. This was the third consolidated... More

Globus Medical (GMED) PT Raised to $79 at Truist Securities

August 7, 2024 6:08 AM EDT

Truist Securities analyst Richard Newitter raised the price target on Globus Medical (NYSE: GMED) to $79.00 (from $78.00) while maintaining a Hold rating.

The analyst comments "GMED delivered a good qtr, post-deal integration with dissynergies no worse than feared, and mgmt appears on... More

Globus Medical (GMED) PT Raised to $100 at Roth/MKM

August 7, 2024 5:17 AM EDT

Roth/MKM analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 (from $75.00) while maintaining a Buy rating.

The analyst comments "GMED reported 2Q24 revenues of $629.7 million compared to consensus of $615.3 million, and adjusted EPS of $0.75 compared to consensus of $0.68. Adjusted... More